Kevin Rakin's Net Worth

$1.03 Million

Estimate Recalculated Jun 12, 2025 08:30PM EST

Who is Kevin Rakin

Kevin Rakin has an estimated net worth of $1.03 Million. This is based on reported shares across multiple companies, which include Omrix Biopharmaceuticals, Inc., GENAISSANCE PHARMACEUTICALS INC, HISTOGENICS CORP, ORAMED PHARMACEUTICALS INC., Quantum-Si Inc, ELUTIA INC., VION PHARMACEUTICALS INC, and CLINICAL DATA INC.

SEC CIK

Kevin Rakin's CIK is 0001184421

Past Insider Trading and Trends

2021 was Kevin Rakin's most active year for acquiring shares with 7 total transactions. Kevin Rakin's most active month to acquire stocks was the month of November. 2021 was Kevin Rakin's most active year for disposing of shares, totalling 10 transactions. Kevin Rakin's most active month to dispose stocks was the month of July. 2006 saw Kevin Rakin paying a total of $1,298,500.00 for 84,360 shares, this is the most they've acquired in one year. In 2021 Kevin Rakin cashed out on 131,329 shares for a total of $993,131.29, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Omrix Biopharmaceuticals, Inc.

Investor
Updated Sep 05, 2008
Form 4
34.29%
12.00K
Sep 05, 2008
47.00K
Grant
Sep 04
Form 4
100.00%
2.00K
$13.65
$27.30K
Mar 28, 2008
4.00K
Purchase
Mar 26
Form 4
22.00K
Jun 01, 2007
2.00K
Grant
May 31
Form 4
11.00K
Jan 18, 2007
Grant
Jan 16
Form 3
Jan 18, 2007
Showing 5 results

GENAISSANCE PHARMACEUTICALS INC

President & CEO
Updated Oct 06, 2005
Form 4
-100.00%
-1.69M
Oct 06, 2005
Disposition
Oct 06
Form 4
29.20%
170.00K
$2.20
$297.04K
Jan 21, 2005
827.39K
Grant
Jan 07
Form 4
9.84%
57.50K
$3.74
$224.40K
Apr 29, 2004
717.39K
Grant
Feb 23 - Apr 27
Form 4
140.00K
$2.56
$358.40K
Dec 11, 2003
140.00K
Grant
Dec 09
Showing 4 results

HISTOGENICS CORP

Investor
Updated Feb 11, 2019
Form 4
Feb 11, 2019
809.82K
Options
Feb 08
Form 4
2,729.60%
403.84K
Oct 11, 2018
632.04K
Purchase
Oct 10
Form 4
25.00K
Jun 19, 2018
25.00K
Grant
Jun 15
Form 4
25.00K
Jun 14, 2017
25.00K
Grant
Jun 13
Form 4
10.00K
Dec 19, 2016
10.00K
Grant
Dec 16
Form 4
164.97%
142.08K
Dec 02, 2016
228.20K
Options
Nov 30
Form 4
-121.77%
-142.72K
$501.13
-$240.78K
Oct 03, 2016
263.90K
Grant
Sep 29
Form 4
20.00K
Jun 26, 2015
20.00K
Grant
Jun 24
Form 4
11.30%
11.07K
$10.92
Dec 08, 2014
109.03K
Purchase
Dec 08
Form 3
Dec 02, 2014
13.21K
Showing 10 results

ORAMED PHARMACEUTICALS INC.

Investor
Updated Mar 22, 2022
Form 4
-17.65%
-10.00K
$9.41
-$94.10K
Mar 22, 2022
46.66K
Sale
Mar 21
Form 4
-5.04%
-3.01K
$7.72
$5.30
Feb 22, 2022
56.66K
Options
Feb 17
Form 4/A
-8.62%
-5.00K
Feb 15, 2022
53.00K
Grant
Feb 11
Form 4
-9.61%
-5.00K
Feb 14, 2022
47.00K
Grant
Feb 11
Form 4
30.77%
16.00K
Jan 05, 2022
68.00K
Grant
Jan 03
Form 4
-8.77%
-5.00K
Dec 17, 2021
52.00K
Grant
Dec 16
Form 4
-27.02%
-21.10K
$20.99
-$442.83K
Sep 20, 2021
57.00K
Sale
Sep 16
Form 4
14.68%
10.00K
Sep 02, 2021
78.10K
Grant
Aug 31
Form 4
-27.70%
-26.09K
$14.02
$13.95
Aug 11, 2021
68.10K
Options
Aug 09
Form 4
15.00K
Feb 17, 2021
15.00K
Grant
Feb 17
Form 4
20.00K
Jan 14, 2020
20.00K
Grant
Jan 08
Form 4
Sep 16, 2019
10.00K
Acq/Dis
Apr 10 - Sep 12
Form 4
10.00K
Apr 12, 2019
10.00K
Grant
Apr 10
Form 4
56.77K
Jul 05, 2017
56.77K
Grant
Jun 30
Form 4
5.70K
Feb 16, 2017
5.70K
Grant
Feb 09
Form 4
59.19%
5.60K
$6.50
$36.43K
Dec 07, 2016
15.06K
Grant
Dec 05 - Dec 06
Form 4
9.46K
$6.18
$58.43K
Dec 05, 2016
9.46K
Grant
Dec 01 - Dec 02
Form 3
Sep 08, 2016
Showing 18 results

Quantum-Si Inc

Chairman and CEO
Updated May 17, 2024
Form 4
113.28K
May 17, 2024
113.28K
Grant
May 16
Form 4
120.48K
May 16, 2023
120.48K
Grant
May 12
Form 4
-33.37%
-601.00K
Dec 22, 2022
1.22M
Disposition
Dec 20
Form 4
-4.71%
-89.00K
$2.15
-$191.23K
Dec 16, 2022
1.82M
Sale
Dec 15
Form 4
59.88K
May 13, 2022
59.88K
Grant
May 11
Form 4
1.92M
$10.00
$19.01M
Jun 15, 2021
1.92M
Grant
Jun 10 - Jun 11
Form 3
Sep 03, 2020
Showing 7 results

ELUTIA INC.

Investor
Updated Aug 01, 2024
Form 4
$1.43
$3.00M
Aug 01, 2024
9.10M
Options
Jul 30
Form 4
47.75K
Jun 10, 2024
47.75K
Grant
Jun 06
Form 4
-28.29%
-3.59M
Jan 08, 2024
9.10M
Disposition
Dec 28
Form 4
126.71%
7.09M
Oct 05, 2023
12.69M
Purchase
Sep 21
Form 4
62.50K
Jun 12, 2023
62.50K
Grant
Jun 08
Form 4
17.53K
Dec 27, 2022
17.53K
Grant
Dec 22
Form 4
15.12%
735.00K
$4.75
$3.49M
Dec 07, 2022
5.69M
Purchase
Dec 05
Form 4
44.18K
Jun 09, 2022
44.18K
Grant
Jun 07
Form 4
9.09%
412.74K
$4.24
$1.75M
Dec 10, 2021
4.95M
Purchase
Dec 08
Form 4
28.16K
Jun 09, 2021
28.16K
Grant
Jun 07
Form 4
-85.52%
-26.63M
$11.12
$7.53M
Oct 13, 2020
4.54M
Buy-Options
Oct 13
Form 3
Oct 07, 2020
31.85K
Showing 12 results

VION PHARMACEUTICALS INC

Investor
Updated Dec 12, 2008
Form 4
18.53%
1.13K
Dec 12, 2008
7.23K
Grant
Dec 11
Form 4
22.74%
11.30K
Jun 28, 2007
61.00K
Grant
Jun 27
Form 4
43.23%
15.00K
$1.59
$23.85K
Mar 15, 2007
49.70K
Purchase
Mar 13
Form 4
34.70K
Jan 17, 2007
34.70K
Grant
Jan 15
Form 3
Jan 17, 2007
Showing 5 results

CLINICAL DATA INC

Investor
Updated Nov 27, 2006
Form 4
-25.05%
-10.00K
$16.18
-$161.81K
Nov 27, 2006
36.43K
Sale
Nov 20
Form 4
14.36K
Sep 25, 2006
14.36K
Grant
Sep 21
Form 4
-1.33%
-540.00
Aug 22, 2006
46.43K
Grant
Aug 08
Form 4
70.00K
$18.55
$1.30M
May 16, 2006
70.00K
Grant
May 12
Form 4
9.88%
3.75K
$19.56
$48.91K
Nov 21, 2005
48.22K
Grant
Nov 17
Form 3
Oct 19, 2005
44.47K
Showing 6 results